a href=”/practice/overview.htm?topic=Serzone”>More information on Serzone side effects
An anti-depressant drug called nefazodone is being pulled from the market because it has been linked to serious liver damage, Health Canada says.
“This risk, while very remote, poses a greater risk than other similar anti-depressants currently available in Canada,” the federal department said.
Nefazodone is a prescription-only product approved in 1994 and sold under the trade name Serzone by Bristol-Myers Squibb Canada Inc.
It is also sold under the generic names Lin-Nefazodone, Apo-Nefazodone, Nefazodone, Dom-Nefazodone, Novo-Nefazodone-5HT2, PMS-Nefazodone and Gen-Nefazodone.
Health Canada says it is aware of 38 Canadian cases of liver-related adverse effects, including one death, believed to be associated with the drug from 1994 until the end of last year.
Bristol-Myers Squibb and Linson Pharma agreed to have their products withdrawn by Thursday.